PER 0.00% 10.5¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-376

  1. 3,619 Posts.
    lightbulb Created with Sketch. 783

    Unfortunate for the patients but this failure just puts ANP in the top position with our outstanding results from the DMD trial and other indications....Matter of times as big Pharma is going to wipe us out ..as George said a few months ago ..this will be a very different looking ANP by Christmas...if we survive ..
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.